Cyto share price
WebThe stock price for . Altamira Therapeutics (NASDAQ: CYTO) is $2.07 last updated April 10, 2024 at 8:00 PM UTC. Q Does Altamira Therapeutics (CYTO) pay a dividend? WebAltamira Therapeutics Ltd. analyst ratings, historical stock prices, earnings estimates & actuals. CYTO updated stock price target summary.
Cyto share price
Did you know?
WebThe current Altamira Therapeutics share price is $2.48. The Score for CYTO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. CYTO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels. Web1 day ago · CYTO Complete Altamira Therapeutics Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
WebApr 6, 2024 · A high-level overview of Altamira Therapeutics Ltd. (CYTO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebFind the latest CytomX Therapeutics, Inc. (CTMX) stock quote, history, news and other vital information to help you with your stock trading and investing.
WebApr 13, 2024 · Altamira Therapeutics has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500. Comparatively, Viracta Therapeutics has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Insider and Institutional Ownership Web1 day ago · Share Statistics. CYTO has 2.39 million shares outstanding. The number of shares has increased by 262.69% in one year. Shares Outstanding 2.39M: Shares Change (YoY) +262.69% ... Stock Price Statistics. The stock price has decreased by -91.11% in the last 52 weeks. The beta is 1.41, so CYTO's price volatility has been higher than the …
WebApr 10, 2024 · Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results. HAMILTON, BERMUDA, Nov. 30, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today provided... 4 months ago - GlobeNewsWire.
Web1 day ago · Today’s news has shares of CYTO stock seeing heavy trading volume. As of this writing, more than 2.1 million shares of the stock have changed hands. For … da baby and anthony hamiltonWeb1 day ago · In other developments, Altamira Therapeutics (NASDAQ:CYTO) skyrocketed after releasing phase 2 results on its vertigo medication. ... The firm had set a price target of $65 per share, representing ... bing search history will not deleteWebSign me up for CYTO 2024 information. * indicates required. Email Address *. First Name. Last Name. Opt-In. By filling out this form, I provide consent that my entry will be stored with ISAC for the purpose of doing business … bing search history pageWebApr 12, 2024 · The current price is about -21574.24% off the estimated low and -21574.24% off the forecast high, based on this estimate. Investors will be thrilled if CYTO’s share … bing search history today deleteWebAltamira Therapeutics Ltd. analyst estimates, including CYTO earnings per share estimates and analyst recommendations. ... Average Target Price: 286.10: Number Of Ratings: 1: FY Report Date: 12/2024: dababy amogus sus schoolWebPrice/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. Price/Book: A financial ratio used to compare a company's current market price … dababy and b simone kissWebView live Altamira Therapeutics Ltd chart to track its stock's price action. Find market predictions, CYTO financials and market news. View live Altamira Therapeutics Ltd chart to track its stock's price action. ... CYTO CYTO AVCT Minimum time of 15 days and a maximum of 2 months you will see a movement from these levels between 40-100% up … bing search history ip